Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seyed Moayed Alavian

Showing results (271-280 of 327) with videos related to

Pageof 33
Sort By:
BMJ Open|July 13, 2017
Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocolSeyed Ali Jazayeri-Tehrani, Seyed Mahdi Rezayat, Siavash Mansouri, et al.
Gastroenterology and Hepatology From Bed to Bench|May 17, 2014
Using statistical models to assess medical cost of hepatitis C virusMohsen Vahedi, Asma Pourhoseingholi, Sara Ashtari, et al.
Nutrition & Metabolism|September 29, 2018
Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trialMilad Daneshi-Maskooni, Seyed Ali Keshavarz, Mostafa Qorbani, et al.
Hepatitis Monthly|October 8, 2013
Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients with unusual clinical picturesShiva Ghamari, Seyed Moayed Alavian, Mario Rizzetto, et al.
Hepatitis Monthly|November 25, 2014
Immunogenicity of Multi-Epitope DNA and Peptide Vaccine Candidates Based on Core, E2, NS3 and NS5B HCV Epitopes in BALB/c MiceLeila Pishraft Sabet, Tahereh Taheri, Arash Memarnejadian, et al.
Hepatitis Monthly|May 16, 2015
Economic burden of hepatitis B virus-related diseases: evidence from iranKhosro Keshavarz, Abbas Kebriaeezadeh, Seyed Moayed Alavian, et al.
World Journal of Gastroenterology|September 1, 2010
Non-alcoholic steatohepatitis and influence of age and gender on histopathologic findingsNargess Ebrahimi Daryani, Nasser Ebrahimi Daryani, Seyed Moayed Alavian, et al.
Archives of Virology|October 29, 2014
Enhancement of HCV polytope DNA vaccine efficacy by fusion to an N-terminal fragment of heat shock protein gp96Leila Pishraft-Sabet, Anna D Kosinska, Sima Rafati, et al.
BMC Complementary and Alternative Medicine|March 16, 2019
Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trialMilad Daneshi-Maskooni, Seyed Ali Keshavarz, Mostafa Qorbani, et al.
The Lancet. Gastroenterology & Hepatology|March 13, 2019
Mass migration to Europe: an opportunity for elimination of hepatitis B virus?Marijn Thijssen, Philippe Lemey, Samad Amini-Bavil-Olyaee, et al.
Pageof 33

Showing results (271-280 of 327) with videos related to

Sort By:
Pageof 33
BMJ Open|July 13, 2017
Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocolSeyed Ali Jazayeri-Tehrani, Seyed Mahdi Rezayat, Siavash Mansouri, et al.
Gastroenterology and Hepatology From Bed to Bench|May 17, 2014
Using statistical models to assess medical cost of hepatitis C virusMohsen Vahedi, Asma Pourhoseingholi, Sara Ashtari, et al.
Nutrition & Metabolism|September 29, 2018
Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trialMilad Daneshi-Maskooni, Seyed Ali Keshavarz, Mostafa Qorbani, et al.
Hepatitis Monthly|October 8, 2013
Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients with unusual clinical picturesShiva Ghamari, Seyed Moayed Alavian, Mario Rizzetto, et al.
Hepatitis Monthly|November 25, 2014
Immunogenicity of Multi-Epitope DNA and Peptide Vaccine Candidates Based on Core, E2, NS3 and NS5B HCV Epitopes in BALB/c MiceLeila Pishraft Sabet, Tahereh Taheri, Arash Memarnejadian, et al.
Hepatitis Monthly|May 16, 2015
Economic burden of hepatitis B virus-related diseases: evidence from iranKhosro Keshavarz, Abbas Kebriaeezadeh, Seyed Moayed Alavian, et al.
World Journal of Gastroenterology|September 1, 2010
Non-alcoholic steatohepatitis and influence of age and gender on histopathologic findingsNargess Ebrahimi Daryani, Nasser Ebrahimi Daryani, Seyed Moayed Alavian, et al.
Archives of Virology|October 29, 2014
Enhancement of HCV polytope DNA vaccine efficacy by fusion to an N-terminal fragment of heat shock protein gp96Leila Pishraft-Sabet, Anna D Kosinska, Sima Rafati, et al.
BMC Complementary and Alternative Medicine|March 16, 2019
Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trialMilad Daneshi-Maskooni, Seyed Ali Keshavarz, Mostafa Qorbani, et al.
The Lancet. Gastroenterology & Hepatology|March 13, 2019
Mass migration to Europe: an opportunity for elimination of hepatitis B virus?Marijn Thijssen, Philippe Lemey, Samad Amini-Bavil-Olyaee, et al.
Pageof 33